Recombinant Escherichia coli O45:K1 ATP synthase subunit alpha (atpA)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder. We will ship the available format, but please specify any format requirements when ordering.
Lead Time
Delivery times vary. Consult local distributors for specific delivery information. Proteins are shipped with blue ice packs by default. Request dry ice in advance for an extra fee.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you require a specific tag, please inform us and we will prioritize its development.
Synonyms
atpA; ECS88_4156ATP synthase subunit alpha; EC 7.1.2.2; ATP synthase F1 sector subunit alpha; F-ATPase subunit alpha
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-513
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Escherichia coli O45:K1 (strain S88 / ExPEC)
Target Names
atpA
Target Protein Sequence
MQLNSTEISE LIKQRIAQFN VVSEAHNEGT IVSVSDGVIR IHGLADCMQG EMISLPGNRY AIALNLERDS VGAVVMGPYA DLAEGMKVKC TGRILEVPVG RGLLGRVVNT LGAPIDGKGP LDHDGFSAVE AIAPGVIERQ SVDQPVQTGY KAVDSMIPIG RGQRELIIGD RQTGKTALAI DAIINQRDSG IKCIYVAIGQ KASTISNVVR KLEEHGALAN TIVVVATASE SAALQYLAPY AGCAMGEYFR DRGEDALIIY DDLSKQAVAY RQISLLLRRP PGREAFPGDV FYLHSRLLER AARVNAEYVE AFTKGEVKGK TGSLTALPII ETQAGDVSAF VPTNVISITD GQIFLETNLF NAGIRPAVNP GISVSRVGGA AQTKIMKKLS GGIRTALAQY RELAAFSQFA SDLDDATRKQ LDHGQKVTEL LKQKQYAPMS VAQQSLVLFA AERGYLADVE LSKIGSFEAA LLAYVDRDHA PLMQEINQTG GYNDEIEGKL KGILDSFKAT QSW
Uniprot No.

Target Background

Function
Generates ATP from ADP using a proton gradient across the membrane. The alpha chain is a regulatory subunit.
Database Links
Protein Families
ATPase alpha/beta chains family
Subcellular Location
Cell inner membrane; Peripheral membrane protein.

Q&A

What is the ATP synthase complex and what role does the alpha subunit play?

The F1F0 ATP synthase is the central enzyme complex of the mitochondrial oxidative phosphorylation system, responsible for synthesizing ATP from ADP and Pi using energy stored by the electron transport chain. The mammalian mitochondrial ATP synthase is a multisubunit enzyme complex comprising 14 different polypeptides, with two encoded by the mitochondrial genome . The alpha subunit (atpA) is a critical component of the F1 catalytic sector that participates directly in the rotational catalysis mechanism essential for ATP production. While structurally distinct from the c subunit (atpE), both are integral to the proper assembly and function of the complete ATP synthase complex .

How is the expression of the ATPA gene regulated at the transcriptional level?

The ATPA gene expression is regulated through multiple mechanisms:

What are the physicochemical properties of the recombinant ATP synthase alpha subunit?

While specific data for the alpha subunit (atpA) is not directly provided in the search results, we can draw comparisons with the well-characterized ATP synthase c subunit (atpE) properties:

PropertyTypical CharacteristicsNotes
Molecular Weight~55-60 kDa (alpha subunit)Higher than atpE's ~8 kDa
SolubilityModerately hydrophobicRequires appropriate buffer conditions
StabilitySensitive to freeze-thaw cyclesStorage at -20°C/-80°C recommended
Storage BufferTypically Tris/PBS-based buffer with stabilizersSimilar to atpE's buffer (Tris/PBS-based, 6% Trehalose, pH 8.0)
Recommended Concentration0.1-1.0 mg/mL after reconstitutionGlycerol (5-50%) addition recommended for long-term storage

Research with recombinant proteins generally requires careful handling and storage practices, including avoiding repeated freeze-thaw cycles and proper aliquoting for multiple use scenarios .

What are the optimal conditions for expressing recombinant ATP synthase alpha subunit in E. coli expression systems?

For optimal expression of recombinant ATP synthase alpha subunit in E. coli systems, researchers should consider the following methodological approach:

  • Expression vector selection: Use vectors with strong, inducible promoters (T7, tac, or pBAD) to control expression levels.

  • E. coli strain considerations: BL21(DE3) or derivatives are typically preferred for recombinant protein expression due to their reduced protease activity.

  • Expression conditions:

    • Growth temperature: Lower temperatures (16-25°C) often improve proper folding

    • Induction parameters: IPTG concentration (typically 0.1-1.0 mM)

    • Growth media: Rich media (LB) for high yield or minimal media for isotope labeling

    • Expression duration: 3-6 hours post-induction for standard protocols, 16-20 hours for low-temperature expression

  • Solubility enhancement: For membrane-associated proteins like ATP synthase components, consider:

    • Fusion tags: His-tags facilitate purification but may affect protein functionality

    • Detergents: Non-ionic detergents may be necessary during extraction and purification

    • Chaperone co-expression: GroEL/GroES system may improve folding

Similar to other ATP synthase components, the alpha subunit may require specialized protocols to maintain structural integrity during expression .

What purification strategies yield the highest purity and activity for recombinant ATP synthase alpha subunit?

A multi-step purification strategy is typically required to obtain highly pure and active ATP synthase alpha subunit:

  • Initial capture:

    • Immobilized metal affinity chromatography (IMAC) for His-tagged constructs

    • Gentle cell lysis techniques to preserve protein structure

    • Buffer optimization to maintain stability (typically containing 20-50 mM Tris-HCl, pH 7.5-8.0, 100-300 mM NaCl)

  • Secondary purification:

    • Ion exchange chromatography to separate based on charge characteristics

    • Size exclusion chromatography for final polishing and buffer exchange

    • Removal of aggregates and improperly folded proteins

  • Quality assessment:

    • SDS-PAGE analysis (target purity >90%)

    • Western blotting for identity confirmation

    • Activity assays to confirm functional integrity

  • Storage considerations:

    • Lyophilization or solution storage based on stability data

    • Aliquoting to avoid repeated freeze-thaw cycles

    • Addition of stabilizers (e.g., glycerol at 5-50%) for long-term storage

    • Storage at -20°C/-80°C with careful handling protocols

Final purity should be verified using analytical techniques such as SDS-PAGE, with expected purity levels exceeding 90% for research applications.

How can researchers accurately assess the enzymatic activity of purified recombinant ATP synthase alpha subunit?

Assessment of enzymatic activity requires considering both the isolated alpha subunit and its contribution to the holoenzyme complex:

  • Individual subunit analysis:

    • ATP binding assays using fluorescent ATP analogs

    • Conformational change monitoring via intrinsic tryptophan fluorescence

    • Circular dichroism to assess secondary structure integrity

  • Reconstituted complex activity:

    • ATP hydrolysis assays (coupled enzyme systems)

    • Proton pumping assays in reconstituted liposomes

    • ATP synthesis measurements in properly oriented proteoliposomes

  • Data interpretation considerations:

    • The alpha subunit alone will show different characteristics than when assembled in the complete F1F0 complex

    • Control experiments with known inhibitors (oligomycin, DCCD) help validate assay specificity

    • Comparison to wild-type activity levels provides functional benchmarks

  • Methodological parameters:

    • Temperature: Typically 30°C or 37°C depending on the assay

    • Buffer composition: Including essential ions (Mg2+) and pH optimization

    • Substrate concentrations: ATP/ADP levels determine kinetic parameters

Activity data should be reported as specific activity (μmol substrate/min/mg protein) to enable comparison across different preparations and laboratories.

How do mutations in the ATPA gene affect ATP synthase assembly and function?

Understanding the impact of mutations in the ATPA gene requires sophisticated analysis of both structural and functional consequences:

  • Structure-function relationships:

    • Mutations in nucleotide binding domains directly impact catalytic function

    • Interface mutations can disrupt interactions with other F1 subunits (β, γ)

    • Distant mutations may cause allosteric effects altering enzyme kinetics

  • Assembly defects:

    • Some mutations permit alpha subunit expression but prevent proper incorporation into the F1 complex

    • Partially assembled complexes may form but exhibit compromised stability

    • Interference with the sequential assembly pathway can yield heterogeneous enzyme populations

  • Experimental approaches to characterize mutations:

    • Site-directed mutagenesis followed by expression and purification

    • Comparative structural analysis using crystallography or cryo-EM

    • Functional assays comparing wild-type and mutant forms

    • In vivo complementation studies to assess biological significance

  • Molecular dynamics simulations:

    • Computational analysis of structural perturbations

    • Prediction of altered energy landscape during catalytic cycle

    • Identification of compensatory mutations that restore function

These studies provide crucial insights into both basic enzyme mechanisms and potential therapeutic targets for diseases associated with ATP synthase dysfunction .

What is the relationship between transcriptional regulation of the ATPA gene and cellular energy demands?

The relationship between ATPA gene regulation and cellular energy demands represents a sophisticated area of research:

  • Regulatory network integration:

    • Upstream stimulatory factor 2 (USF2) transactivates the ATPA gene through its initiator element

    • YY1 binding to the initiator element provides positive regulation

    • Competition between USF2 and YY1 suggests a complex regulatory mechanism that may respond differently to varied cellular conditions

  • Metabolic sensor interactions:

    • Transcription factors responding to cellular energy status may coordinate with USF2/YY1

    • Post-translational modifications of these factors could provide rapid response mechanisms

    • Integration with broader mitochondrial biogenesis pathways involving PGC-1α, NRF1, and NRF2

  • Tissue-specific regulation:

    • ATP synthesis requirements vary widely among tissues

    • Differential expression during development, differentiation, and cellular proliferation

    • Specialized regulatory mechanisms may exist in high-energy-demanding tissues

  • Experimental approaches:

    • ChIP-seq to identify binding of energy-sensing transcription factors

    • Reporter gene assays under various metabolic conditions

    • Metabolic manipulation coupled with gene expression analysis

    • CRISPR-mediated deletion of regulatory elements

This research area bridges transcriptional regulation with bioenergetics and has implications for understanding disease states associated with energy metabolism disorders .

How does the alpha subunit contribute to the rotational catalysis mechanism of ATP synthase?

The alpha subunit plays a sophisticated role in the rotational catalysis mechanism:

  • Structural contributions to catalytic sites:

    • Alpha subunits form part of the three catalytic sites at alpha-beta interfaces

    • Each site cycles through different conformational states (loose, tight, open)

    • Structural elements of the alpha subunit create specific binding environments

  • Conformational changes during catalysis:

    • Alpha subunits undergo coordinated conformational changes driven by gamma subunit rotation

    • These changes alter binding affinities for substrates and products

    • The precise sequence of conformational changes ensures catalytic efficiency

  • Experimental approaches to study rotational dynamics:

    • Single-molecule FRET to track conformational changes

    • High-resolution cryo-EM to capture intermediates

    • Biochemical cross-linking to trap specific rotational states

    • Computational simulations of the complete catalytic cycle

  • Comparative analysis across species:

    • Conservation of critical residues in alpha subunits

    • Species-specific variations that may affect catalytic properties

    • Evolutionary insights into the optimization of energy conversion efficiency

Understanding these mechanisms has implications for both fundamental bioenergetics and the development of novel antibiotics targeting bacterial ATP synthases .

What analytical techniques are most effective for characterizing structural features of recombinant ATP synthase alpha subunit?

Comprehensive structural characterization requires multiple complementary techniques:

Integration of multiple techniques provides the most comprehensive understanding of structure-function relationships. For example, crystallographic data can provide the baseline structure, while HDX-MS and fluorescence studies can reveal dynamic properties relevant to catalytic function .

How can researchers effectively troubleshoot expression and purification issues with recombinant ATP synthase alpha subunit?

Systematic troubleshooting approaches are essential for addressing common challenges:

  • Low expression yield:

    • Optimize codon usage for E. coli expression

    • Test different promoter systems and induction conditions

    • Evaluate strain-specific factors (protease deficiency, rare tRNA supplementation)

    • Consider co-expression with chaperones

  • Protein solubility issues:

    • Modify buffer conditions (pH, ionic strength, additives)

    • Test different cell lysis methods to preserve native structure

    • Evaluate fusion partners or solubility tags

    • Implement on-column refolding strategies

  • Purification challenges:

    • Optimize binding and elution conditions for affinity chromatography

    • Implement orthogonal purification steps to remove contaminants

    • Analyze protein behavior using analytical SEC to identify aggregation

    • Modify tag position (N- vs. C-terminal) if interference is suspected

  • Stability problems:

    • Screen stabilizing additives (glycerol, trehalose, specific ions)

    • Identify and control proteolytic degradation with inhibitor cocktails

    • Implement appropriate storage conditions to maintain activity

    • Consider site-directed mutagenesis of unstable regions

Documentation of systematic troubleshooting in a research notebook allows for progressive optimization and provides valuable information for publication methods sections .

What controls and validation experiments are essential when studying transcriptional regulation of the ATPA gene?

  • Reporter gene assays:

    • Positive controls with known strong promoters

    • Negative controls with promoterless constructs

    • Serial deletions of regulatory regions to map functional elements

    • Site-directed mutagenesis of specific binding sites

    • Dominant-negative transcription factor constructs to validate specificity

  • Binding studies:

    • Electrophoretic mobility shift assays (EMSA) with purified factors

    • Competition assays with unlabeled wild-type and mutant probes

    • Supershift assays with specific antibodies to confirm factor identity

    • DNase I footprinting to precisely map binding sites

  • In vivo validation:

    • Chromatin immunoprecipitation (ChIP) to confirm binding in cellular context

    • Correlation of transcription factor levels with ATPA expression

    • Knockdown/knockout studies using RNAi or CRISPR-Cas9

    • Rescue experiments with wild-type and mutant constructs

  • Functional correlation:

    • ATP synthase activity measurements in cells with modified ATPA regulation

    • Cellular ATP levels and mitochondrial function assessment

    • Metabolic flux analysis to evaluate broader energetic consequences

For example, research has demonstrated that cotransfection of a dominant-negative USF2 mutant significantly reduced both basal activity and the level of activation of the ATPA initiator by coexpressed USF2, effectively validating the role of endogenous USF2 proteins in ATPA gene regulation .

How can researchers integrate structural and functional data to develop comprehensive models of ATP synthase alpha subunit dynamics?

Integrating structural and functional data requires sophisticated computational approaches:

  • Multi-scale modeling framework:

    • Atomic-level molecular dynamics simulations of the alpha subunit

    • Coarse-grained models to capture larger conformational changes

    • Systems biology models linking structure-function to cellular energetics

    • Integration of experimental constraints from multiple techniques

  • Data integration methodology:

    • Structural data from X-ray crystallography and cryo-EM as baseline models

    • Functional data from enzyme kinetics to validate catalytic predictions

    • Spectroscopic data to inform on conformational dynamics

    • Mutation effects to validate critical residues and interactions

  • Visualization and analysis tools:

    • Principal component analysis to identify major conformational modes

    • Network analysis to identify allosteric communication pathways

    • Energy landscape mapping to characterize conformational transitions

    • Comparative analysis across homologous proteins from different species

  • Validation approaches:

    • Prediction of novel mutations affecting function

    • Design of experiments to test model-derived hypotheses

    • Refinement through iterative experimental-computational cycles

    • Statistical evaluation of model consistency with experimental observables

This integrative approach yields testable hypotheses about structure-function relationships that can guide future experimental design and potentially inform therapeutic interventions targeting bacterial ATP synthases.

What emerging technologies show promise for studying ATP synthase alpha subunit structure and function?

Several cutting-edge technologies are poised to revolutionize ATP synthase research:

  • Cryo-electron tomography:

    • Visualization of ATP synthase in its native membrane environment

    • Mapping of supramolecular organization and interactions

    • Resolution of structural heterogeneity within single cells

  • Time-resolved spectroscopy:

    • Ultrafast laser techniques to capture transient catalytic states

    • Correlation of structural dynamics with functional cycles

    • Direct observation of conformational coupling mechanisms

  • Advanced computational methods:

    • Quantum mechanics/molecular mechanics (QM/MM) simulations for catalytic mechanism

    • Machine learning approaches to predict function from sequence

    • Enhanced sampling techniques for rare event observation

  • Single-molecule approaches:

    • High-speed AFM to visualize conformational dynamics

    • Magnetic tweezers to measure rotational torque generation

    • Single-molecule FRET with multiple fluorophores to track subunit movements

These technologies promise to provide unprecedented insights into the dynamic behavior of ATP synthase components and may lead to novel therapeutic strategies targeting bacterial bioenergetics.

How might understanding ATPA gene regulation contribute to development of new antimicrobial strategies?

The potential for targeting ATPA regulation as an antimicrobial strategy presents several research avenues:

  • Species-specific regulatory mechanisms:

    • Identification of regulatory elements unique to bacterial ATPA genes

    • Characterization of transcription factor binding sites with structural differences

    • Analysis of regulatory network differences between bacterial and mammalian systems

  • Molecular targeting approaches:

    • Small molecule screening against bacterial transcription factors like USF2

    • Development of peptide inhibitors mimicking binding interfaces

    • RNA-based therapeutics to interfere with ATPA mRNA translation

  • Functional consequences of intervention:

    • Metabolic modeling to predict system-wide effects of ATPA downregulation

    • In vitro and in vivo assessment of growth inhibition and virulence

    • Resistance development potential through compensatory mechanisms

  • Combination strategy development:

    • Synergistic effects with existing antibiotics

    • Multi-target approaches affecting both expression and function

    • Host-directed therapies modulating bacterial energy requirements

This approach represents a novel paradigm in antimicrobial development by targeting energy production at the transcriptional level rather than through direct enzyme inhibition .

What are the challenges and opportunities in developing ATP synthase-targeted therapeutics against pathogenic E. coli strains?

The development of ATP synthase-targeted therapeutics presents unique challenges and opportunities:

  • Structural selectivity challenges:

    • High conservation of ATP synthase across species limits selectivity

    • Identification of species-specific structural features requires detailed comparative analysis

    • Potential for off-target effects on host ATP synthase

  • Drug delivery considerations:

    • Penetration of bacterial membrane barriers

    • Achieving sufficient local concentration at the target site

    • Formulation strategies for membrane-associated targets

  • Rational drug design opportunities:

    • Structure-based design targeting unique features of bacterial enzyme

    • Allosteric inhibitors affecting assembly or regulation

    • Covalent modifiers with specificity for bacterial-specific residues

  • Resistance development concerns:

    • Potential compensatory mechanisms through metabolic rewiring

    • Mutational escape pathways and their fitness costs

    • Horizontal transfer of resistance determinants

  • Combination therapy approaches:

    • ATP synthase inhibitors with conventional antibiotics

    • Targeting multiple components of oxidative phosphorylation

    • Disruption of both transcriptional regulation and enzyme function

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.